1991
DOI: 10.1164/ajrccm/144.4.909
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Surfactant as a Vehicle for Intratracheal Delivery of Technetium Sulfur Colloid and Pentamidine in Hamster Lungs

Abstract: Tracheal instillation of pentamidine in a surfactant vehicle may be an effective direct method of antibiotic delivery to the lungs. In 10 healthy hamsters, we compared the pulmonary distribution of 99mTc sulfur colloid (TcSC) mixed with pentamidine, using as a vehicle either surfactant (n = 5) or saline (n = 5). Each animal was instilled with 0.25 ml/kg of suspension containing 0.0018 mCi TcSC and pentamidine mixed with either surfactant or saline. After 4 h of spontaneous respiration, the lungs were excised, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
58
0
1

Year Published

1995
1995
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(61 citation statements)
references
References 2 publications
2
58
0
1
Order By: Relevance
“…The use of natural lung surfactant as a drug vehicle for pulmonary administration has been shown to allow deeper and more uniform deposition of instillates within the lungs. 31 However, no modification to overall deposition of the PTH solution was observed when incorporating pure DPPC in the instillate (Figs. 2-4).…”
Section: Discussionmentioning
confidence: 97%
“…The use of natural lung surfactant as a drug vehicle for pulmonary administration has been shown to allow deeper and more uniform deposition of instillates within the lungs. 31 However, no modification to overall deposition of the PTH solution was observed when incorporating pure DPPC in the instillate (Figs. 2-4).…”
Section: Discussionmentioning
confidence: 97%
“…It has been repeatedly shown that intratracheal surfactant administration results in better pulmonary distribution than aerosol and saline administration (28,29). Exogenous surfactant has been shown to enhance the pulmonary delivery and bioavailability of other potential therapeutic agents such as antioxidants, antibiotics, corticosteroids, and adenoviral vectors (8,30).…”
Section: Discussionmentioning
confidence: 99%
“…Exogenous surfactants have also been used to treat other lung disorders such as RDS in mature newborns and adult patients, the meconium aspiration syndrome and pneumonia [4][5][6][7][8][9]. Apart from its ability to lower surface tension, surfactant can also be used as a spreading agent [10][11][12][13].…”
mentioning
confidence: 99%